AEON Biopharma, Inc. (AEON) stock
AEONNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.15−0.01 (-3.59%)
Close on Nov 13, 2026Market cap $7.63MP/E –Yield –
AEON Biopharma cash
Cash and short-term investments held at the end of each period.
AEON Biopharma's cash was $3.43M at Jun 30, 2026. For fiscal 2025 it was $3.01M, up 23023.1% from the year before. The highest annual figure on record is $9.75M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.01M | +23023.1% |
| FY2024 | Dec 31, 2024 | $13.00K | -99.7% |
| FY2023 | Dec 31, 2023 | $5.16M | -47.1% |
| FY2022 | Dec 31, 2022 | $9.75M | +90.1% |
| FY2021 | Dec 31, 2021 | $5.13M | – |
| FY2020 | Dec 31, 2020 | $0 | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.43M | -59.3% |
| Q1 FY2026 | Mar 31, 2026 | $6.24M | -40.2% |
| Q4 FY2025 | Dec 31, 2025 | $3.01M | +23023.1% |
| Q3 FY2025 | Sep 30, 2025 | $5.93M | +1003.7% |
| Q2 FY2025 | Jun 30, 2025 | $8.44M | +145.2% |
| Q1 FY2025 | Mar 31, 2025 | $10.45M | +570.5% |
| Q4 FY2024 | Dec 31, 2024 | $13.00K | -99.7% |
| Q3 FY2024 | Sep 30, 2024 | $537.00K | -96.7% |
| Q2 FY2024 | Jun 30, 2024 | $3.44M | +32.2% |
| Q1 FY2024 | Mar 31, 2024 | $1.56M | -66.8% |
| Q4 FY2023 | Dec 31, 2023 | $5.16M | -47.1% |
| Q3 FY2023 | Sep 30, 2023 | $16.18M | -27.1% |
| Q2 FY2023 | Jun 30, 2023 | $2.60M | +33452.5% |
| Q1 FY2023 | Mar 31, 2023 | $4.69M | +2720.0% |
| Q4 FY2022 | Dec 31, 2022 | $9.75M | +90.1% |
| Q3 FY2022 | Sep 30, 2022 | $22.20M | +3245.8% |
| Q2 FY2022 | Jun 30, 2022 | $7.76K | -99.2% |
| Q1 FY2022 | Mar 31, 2022 | $166.24K | -88.5% |
| Q4 FY2021 | Dec 31, 2021 | $5.13M | – |
| Q3 FY2021 | Sep 30, 2021 | $663.54K | – |
| Q2 FY2021 | Jun 30, 2021 | $988.86K | – |
| Q1 FY2021 | Mar 31, 2021 | $1.44M | – |
| Q4 FY2020 | Dec 31, 2020 | $0 | – |
See a number that looks wrong?